DK167572B1 - 6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler - Google Patents

6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler Download PDF

Info

Publication number
DK167572B1
DK167572B1 DK048785A DK48785A DK167572B1 DK 167572 B1 DK167572 B1 DK 167572B1 DK 048785 A DK048785 A DK 048785A DK 48785 A DK48785 A DK 48785A DK 167572 B1 DK167572 B1 DK 167572B1
Authority
DK
Denmark
Prior art keywords
formula
indole
compound
ethyl
propyl
Prior art date
Application number
DK048785A
Other languages
Danish (da)
English (en)
Other versions
DK48785A (da
DK48785D0 (da
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK48785D0 publication Critical patent/DK48785D0/da
Publication of DK48785A publication Critical patent/DK48785A/da
Application granted granted Critical
Publication of DK167572B1 publication Critical patent/DK167572B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK048785A 1984-02-06 1985-02-04 6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler DK167572B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57709684A 1984-02-06 1984-02-06
US57709684 1984-02-06

Publications (3)

Publication Number Publication Date
DK48785D0 DK48785D0 (da) 1985-02-04
DK48785A DK48785A (da) 1985-09-03
DK167572B1 true DK167572B1 (da) 1993-11-22

Family

ID=24307259

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048785A DK167572B1 (da) 1984-02-06 1985-02-04 6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler

Country Status (24)

Country Link
EP (1) EP0153083B1 (uk)
JP (2) JPH0699388B2 (uk)
KR (1) KR860001892B1 (uk)
AR (1) AR240641A1 (uk)
AT (1) ATE53021T1 (uk)
AU (1) AU572258B2 (uk)
CA (1) CA1291484C (uk)
CY (1) CY1657A (uk)
DE (1) DE3577848D1 (uk)
DK (1) DK167572B1 (uk)
ES (2) ES8605236A1 (uk)
GR (1) GR850313B (uk)
HK (1) HK63792A (uk)
HU (1) HU193941B (uk)
IE (1) IE57916B1 (uk)
IL (1) IL74222A (uk)
MY (1) MY102763A (uk)
NZ (1) NZ211031A (uk)
PH (1) PH20490A (uk)
PT (1) PT79925B (uk)
SG (1) SG66992G (uk)
SU (1) SU1375128A3 (uk)
UA (1) UA5954A1 (uk)
ZA (1) ZA85916B (uk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz] [DC indoles and a process for making their pure enantiomers
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5627199A (en) * 1991-03-28 1997-05-06 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz [CD] indoles
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
EP0724584B1 (en) 1993-07-27 1997-11-05 PHARMACIA & UPJOHN COMPANY Heterocyclic amines having central nervous system activity
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use
FR2732964B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux amides tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US7074927B2 (en) 1999-05-13 2006-07-11 Pharmacia & Upjohn Company Heterocyclic amines having central nervous system activity
TW200732302A (en) * 2005-12-13 2007-09-01 Daicel Chem Indoline derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines

Also Published As

Publication number Publication date
KR860001892B1 (ko) 1986-10-24
EP0153083A2 (en) 1985-08-28
ES8605236A1 (es) 1986-03-16
DE3577848D1 (de) 1990-06-28
AR240641A1 (es) 1990-07-31
SG66992G (en) 1992-09-04
HU193941B (en) 1987-12-28
DK48785A (da) 1985-09-03
IL74222A (en) 1988-07-31
IL74222A0 (en) 1985-05-31
ES8704894A1 (es) 1987-04-16
HK63792A (en) 1992-08-28
JPH0699388B2 (ja) 1994-12-07
SU1375128A3 (ru) 1988-02-15
ES548942A0 (es) 1987-04-16
IE850263L (en) 1985-08-06
NZ211031A (en) 1989-08-29
EP0153083B1 (en) 1990-05-23
EP0153083A3 (en) 1987-01-14
PT79925B (en) 1987-02-05
PT79925A (en) 1985-03-01
JPH06279406A (ja) 1994-10-04
KR850005825A (ko) 1985-09-26
JPH0745470B2 (ja) 1995-05-17
IE57916B1 (en) 1993-05-19
ZA85916B (en) 1986-09-24
ATE53021T1 (de) 1990-06-15
PH20490A (en) 1987-01-21
CA1291484C (en) 1991-10-29
MY102763A (en) 1992-10-31
GR850313B (uk) 1985-06-05
AU572258B2 (en) 1988-05-05
AU3841985A (en) 1985-08-15
CY1657A (en) 1993-05-14
DK48785D0 (da) 1985-02-04
JPS60208959A (ja) 1985-10-21
HUT37121A (en) 1985-11-28
UA5954A1 (uk) 1994-12-29
ES540151A0 (es) 1986-03-16

Similar Documents

Publication Publication Date Title
DK167572B1 (da) 6-substituerede 4-aminotetrahydrobenzoec,daaindoler, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne indoler
EP1192165B1 (en) Substituted heterocycle fused gamma-carbolines
AU679053B2 (en) Indoletetralins having dopaminergic activity
US4576959A (en) 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US7592454B2 (en) Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
US6166040A (en) Indole compounds
AU765317B2 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
US5576336A (en) Indole derivatives as dopamine D4 antagonists
HU193576B (en) Process for production of derivatives of oktahydrobenzo /f/ quinoline
CA2157998A1 (en) Pharmaceutical compounds
US5563147A (en) Serotonerbic tetrahydropyridoindoles
NL193541C (nl) 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
US4983622A (en) 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
US5026869A (en) 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
HUT70051A (en) Novel tricyclic-cyclic amines as cholinesterase inhibitors, pharmaceutical compositions containing them and process for preparing them
NZ233645A (en) 3-(hetero)aryl-substituted-3,4 dehydropiperidine derivatives; preparatory processes and pharmaceutical compositions
FI105022B (fi) Uudet difenyyli-4-perhydroisoindolijohdannaiset, niiden valmistus ja käyttö
JP3174158B2 (ja) ６−オキソ−アゼピノインドール化合物、該化合物を含有する、胃の運動機能を調整する作用を有する医薬品および抗偏頭痛作用するセロトニン拮抗作用を有する医薬品並びに該化合物を製造する方法および該化合物を製造するための中間生成物
CA1107287A (en) Antidepressant carbazoles and intermediates thereto
CA2179634C (en) 4-arylisoindole analgesics
WO2000049017A1 (en) 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
US5773448A (en) Pharmaceutical compounds
SK19412000A3 (sk) Substituované 4,5,6 a 7-indolové alebo indolínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
EP0489547B1 (en) A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof
MXPA96006531A (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed